Sign in
4

Changes in Ownership

Q/C TECHNOLOGIES, INC. Filed Acc 0001683168-26-009018

10% owner acquired 4,982,272 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PharmaCyte Biotech, Inc. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-18 Option exercise : show line 1 in the form +4,982,272 5,152,000 D

Table II: Derivative

2 lines
Date Transaction Shares Expires Underlying Owned after D/I
2026-11-18 Option exercise : show line 2 in the form Series G Long-Term Warrants −851,304 2029-05-23 9,251,513 13,318,344 D
2026-11-18 Other acquisition : show line 3 in the form Series H Convertible Preferred Stock +3,000 2027-09-02 9,674,299 3,000 D
Loading xslF345X06/ownership.xml…